Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis
Abstract Purpose Oncologists, clinical trialists, and guideline developers need tools that enable them to efficiently review the settings and results of previous studies testing metastatic breast cancer (MBC) drug therapies....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer US
2021
|
| Online Access: | https://hdl.handle.net/1721.1/131911 |